Utilizing CRISPR/Cas9-generated mutant lines, we demonstrated that inactivating eIFiso4E-T in the va genetic background not only conferred durable resistance to PVY WT but also blocked infection by PVY RB variants. The gene discussed is RB1; the disease is infection.